Navigation Links
Blundering Doctor Destroys Breast X-ray

A patient's breast X-ray was deliberately destroyed by a doctor who mistakenly gave her the all clear after reading her x-ray according //to a disciplinary panel.

The doctor, consultant surgeon John Philip was working in a private clinic in Sheffield when the woman, a mother-of-two came to him.

The woman she was healthy after routine checks in 1994 and 1996 despite being not qualified to read her X-rays, the General Medical Council (GMC) hearing was told.

Months later she was diagnosed with breast cancer. She died two years later, aged 39, after the cancer spread.

Mr Philip was clinical director of the NHS Pennine Breast Screening Service in Bradford during that time.

The patient, known as Mrs A had left a statement which was read at the hearing in Manchester.

She said: "He said that he had noticed a shelf at the top of my breast. He said that it was the same as it had been then (in 1994) and there was nothing to worry about. He led me to believe that I did not have any problem."

Later, Mrs A felt a pain in her right breast, but thought she had pulled a muscle.

Mrs A's husband was statement was also read to hearing in which he said that he thought she was "in the hands of an expert".

Doctors later found three tumors in her right breast and one under her arm. Her breast was removed following chemotherapy.

Despite the operation, the cancer later spread to her back and ribs, and despite radiotherapy she lost the use of her legs. Mrs A died in May 1998.

However when Mrs A's family began preparing a case for damages they were told the films and the prints had been destroyed.

The lawyers say that the GMC states that the failure to keep that record was not in accordance with NHS standards. Such records were usually kept for a period of eight years.

They added" Their destruction meant they were not available for subsequent comparison
'"/>




Page: 1 2

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Indian Doctor granted US patent on organ regeneration
7. Emphasis to ban Drugs ads by Doctors
8. Doctor samples come under the ambit of advertisement
9. Doctors not to accept gifts from drug companies
10. Gene testing kit specific for Doctors
11. Doctors warned of fluoride toxicity
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Blundering Doctor Destroys Breast ray

(Date:7/25/2008)...nship Based on Significant Improvements in Members...cor, Inc., a leader in health,care quality managem...y,announced it has entered into a long-term agreem...lmark,s Collaboration on Quality(SM) Incent and,Re...tween Wellmark and,primary care clinicians to prom...
(Date:7/25/2008)...if., July 25 /PRNewswire/ -- AutoGenomics, Inc. to...tement on Form S-1 with the,Securities and Exchang...ic,offering of shares of its common stock. The num...f which are expected to be offered by,AutoGenomics... not yet been,determined., J.P. Morgan Securities...
(Date:7/25/2008)... Whether you are an Olympian, Professional...are Five Things You Need to Know about Hydration t...e and Sports Center , Mar...ca,s premier athletes are heading to Beijing follo...acrifice in the hopes of capturing an Olympic meda...
(Date:7/24/2008)... Hoag to lease hospital facility on Sand C...ach, CA (Vocus) July 24, 2008 -- Hoag Memorial Hos...CP, Inc. (NYSE: HCP), a Real Estate Investment Tru...75-bed hospital facility on Sand Canyon Avenue nea...cility is currently operated by Tenet Healthcare C...
Breaking Medicine News(10 mins):Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2
...e Royal Women's Hospital has found that the most c...nduced labor.// Nearly one-third of the women with... caesarians. The factors enhancing the risk of a C...st-time mothers. "The message we are taking is t...
... the University at Buffalo probing into the effect...fish as a model, have zeroed in on many proteins i...negatively with severe alcohol exposure. The scien... out after prolonged alcohol exposure, after they ...
...inister Anbumani Ramadoss has added a new twist to...angerous even without the added pesticides.// "Al...high-risk factors as much as tobacco and a compreh...ed," he said at the golden jubilee year celebratio...
...e University of South Florida College of Medicine ...in Florida is discouraging medical students// from...cialization. The situation means that many people ...n Deutsch, MD, lead author of the study and chief ...
Other Medicine News:Health News:Brain protein expression can be damaged with prolonged alcohol exposure 2Health News:Malpractice Worry Discouraging Medical Students From Taking Up Obstetrics And Gynecology 2
(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ --... of Justice:, Chairman Conyers, Ranking Member Sm...he opportunity to testify today., Since I appeare...ave,become even better acquainted with the talente...tment and with the work they do, and I have come t...
(Date:7/23/2008)... ASPS Study Finds Some Areas of the Body Have G...IGHTS, Ill., July 23 /PRNewswire-USNewswire/ -- Fa...hrough liposuction was found to be,an excellent so...ations,than other areas of the body, reports a Bra...ructive Surgery(R), the official medical journal o...
(Date:7/23/2008)... SEATTLE, July 23 /- Den... that it expects the Independent Data,Monitoring C...rim analysis,of overall survival relating to the C...e AdenoCarcinoma Treatment, also known as D9902B) ...ENGE is the Company,s investigational,active cellu...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-First...d late yesterday, the Board of Progen,Pharmaceutic...ed that it,had discontinued the PI-88 phase 3 stud...direction to develop its existing portfolio of com...re additional compounds and,opportunities through ...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Looking at neurons from all sides 3069 1Looking at neurons from all sides 3069 2deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor Positive Breast Cancer 4893 1deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor Positive Breast Cancer 4893 2deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor Positive Breast Cancer 4893 3deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor Positive Breast Cancer 4893 4deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor Positive Breast Cancer 4893 5Therap Services to Host Conference in Association with the Delaware Division of Developmental Disabilities Services 17817 1Therap Services to Host Conference in Association with the Delaware Division of Developmental Disabilities Services 17817 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 1Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 3Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 4Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 5Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 6Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 7Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 8Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 9
...DNEY, Australia, March 14, 2007 /Xinhua-PRNewswire...day announced the results,from its Phase II trial ...lmonary Disease (COPD), a respiratory disease,affe...l was conducted in 79 diagnosed COPD patients at 1...he trial was to,determine if subjects that were po...
...pany anticipates second quarter BLA filing for C1-... 2007 /PRNewswire-FirstCall/ -- Lev,Pharmaceutical...m,its pivotal U.S. Phase III trial of C1-esterase ...ditary angioedema (HAE). In the,acute study, which...tor in Hereditary Angioedema Nanofiltration Genera...
Other Medicine Technology:Pharmaxis Reports Phase II Results for Aridol in COPD 2Pharmaxis Reports Phase II Results for Aridol in COPD 3Pharmaxis Reports Phase II Results for Aridol in COPD 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: